Stock PGC PARAGON CARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Paragon Care Limited

Equities

PGC

AU000000PGC4

Delayed Australian S.E.
Other stock markets
 08:08:45 2024-05-05 pm EDT 		5-day change 1st Jan Change
0.32 AUD +1.59% Intraday chart for Paragon Care Limited -5.88% +42.22%
Mar. 18 Paragon Care Appoints Interim CFO MT
Mar. 18 ParagonCare Appoints Interim CFO MT

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • With regards to fundamentals, the enterprise value to sales ratio is at 0.9 for the current period. Therefore, the company is undervalued.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Sales forecast by analysts have been recently revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PARAGON CARE LIMITED Stock Paragon Care Limited
+42.22% 139M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
C+
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 67.82B
A
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
B-
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
A-
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PGC Stock
  4. Ratings Paragon Care Limited